Lucas & Mercanti, LLP, Author at Lucas & Mercanti, LLP
April 2, 2024

Why USPTO Should Issue Inherency Guidance Memo

Why USPTO Should Issue Inherency Guidance Memo By Irving Feit · Law360, April 2, 2024 From time to time, the U.S. Patent and Trademark Office issues guidance memos to […]
January 1, 2023

Shintaro Yamada Elected to Partner

Lucas & Mercanti LLP is Pleased to Announce that Shintaro Yamada Has Been Elected to Partner January 1, 2023 | Lucas & Mercanti, LLP Mr. Yamada […]
June 11, 2020

Fed. Circ. Patent Rulings May Shift Use Of Motion To Dismiss

Fed. Circ. Patent Rulings May Shift Use Of Motion To Dismiss By Steven D. Roth, Law360, June 10, 2020 Two recent U.S. Court of Appeals for […]
May 4, 2020
covid-19 drug

INSIGHT: FDA Exclusivities Add Incentives to Covid-19 Drug Race

INSIGHT: FDA Exclusivities Add Incentives to Covid-19 Drug Race By Steven D. Roth, Bloomberg Law, May 4, 2020 Drugmakers are racing to develop a treatment for […]
March 10, 2020

Trademark Specimen Requirements to Demonstrate Use

Trademark Specimen Requirements to Demonstrate Use By Elizabeth Lee D’Amore, March 2020 Generally, an applicant is required to submit to the United States Patent and Trademark […]
February 12, 2020

The Long Odds Of Obtaining IPR Reversals On Issues Of Fact

The Long Odds Of Obtaining IPR Reversals On Issues Of Fact By Steven Roth (Law360, February 11, 2020) Obtaining a reversal of a decision of the […]
July 13, 2019

Michael Mercanti Earns Ranking in 2019 Edition of IAM Patent 1000

Michael Mercanti Earns Ranking in Latest Edition of IAM Patent 1000 07/13/2019 | Lucas & Mercanti co-founder Michael Mercanti is recommended in the 2019 edition of […]